Red flags that should stop the protocol Certain findings should trigger immediate discontinuation of one or both compounds: IGF-1 levels exceeding the age-appropriate upper normal limit on two consecutive tests Fasting glucose rising above 126 mg/dL or HbA1c above 6.5% (indicating new-onset diabetes) Liver enzymes (ALT or AST) exceeding three times the upper limit of normal Persistent severe nausea, vomiting, or abdominal pain suggesting gastroparesis or pancreatitis New or worsening carpal tunnel syndrome symptoms Peripheral edema that does not resolve with fluid management Any sign of an allergic or hypersensitivity reaction These red flags are not exhaustive
21+ only.
Long acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimers disease dementia
Among the genes downregulated in response to GSTO1 siRNA, coagulation factor III ( F3 ), thrombospondin 1 ( THBS1 ), cysteine-rich angiogenic inducer ( CYR61 ) and bone morphogenetic protein 4 ( BMP4 ), related to blood coagulation and blood vessel morphogenesis, were markedly decreased (Supplementary Table 11)
- Benefits: Skin brightening, dark spot fading, tone evening, collagen boosting, antioxidant protection for radiant glow
This often shows up as cognitive fatigue, reduced clarity, and increased stress sensitivity
